March 26, 2008 - TomoTherapy Inc. issued a Treatment Quality Challenge, looking to award $250,000 to any U.S. cancer center that demonstrates its ability to beat the quality of a TomoTherapy treatment plan using the new RapidArc product from Varian Medical Systems.
RapidArc aims to deliver a complete volumetric IMRT treatment in a single arc of the treatment machine around the patient, said Varian. Varian equipment was used to treat a prostate cancer patient with volumetric modulated arc therapy (VMAT) at the BC Cancer Agency in Oct. 2007. Varian has already started taking orders for the RapidArc capability and expects to begin shipping the product in April.
For more information: www.tomotherapy.com, www.varian.com
March 14, 2022 
